Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03113669 · ClinicalTrials.gov registry record · NA

Project BITE: Binge Intervention Target Effectiveness

A NA study of Binge-Eating Disorder, sponsored by Drexel University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03113669 is a NA study of Binge-Eating Disorder that has completed, run by Drexel University. The registered enrollment target is 20 participants, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03113669, a NA study of Binge-Eating Disorder, has completed, sponsored by Drexel University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to determine how inhibitory neurobiological and neurocognitive processes relate to binge eating treatment outcome.

Conditions Studied

Interventions

  • BEHAVIORAL CBT-GSH

Study Locations (1)

Pennsylvania

  • Drexel University - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-10-06
Est. Completion 2018-02-15
Phase NA

Sponsor

Drexel University

92 total trials

What the Registry Record Tells You About NCT03113669

The ClinicalTrials.gov registry entry for NCT03113669 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (98% lower). The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Binge-Eating Disorder appearing as the primary indexed condition, and to 1 intervention - of which CBT-GSH is the first listed.

NCT03113669 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03113669 about?

NCT03113669 is a clinical study titled "Project BITE: Binge Intervention Target Effectiveness". The primary aim of this study is to determine how inhibitory neurobiological and neurocognitive processes relate to binge eating treatment outcome.

What is the current status of trial NCT03113669?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-10-06. Estimated completion is 2018-02-15.

What conditions does trial NCT03113669 study?

This clinical trial studies the following conditions: Binge-Eating Disorder.

What interventions are being tested in trial NCT03113669?

The interventions under investigation include: CBT-GSH (BEHAVIORAL).

Who is sponsoring clinical trial NCT03113669?

This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03113669 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Binge-Eating Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.